# Lecanemab in Early Alzheimer’s Disease

Article · Christopher H. van Dyck, Chad J. Swanson, Paul S. S. Aisen, Randall John Bateman, Christopher Chen, Michelle Gee, Michio Kanekiyo, David Li, Larisa Reyderman, Sharon Cohen, Lutz Froelich, Sadao Katayama, Marwan Sabbagh, Bruno J. Vellas, David Watson, Shobha Dhadda, Michael C. Irizarry, Lynn Darden Kramer, Takeshi Iwatsubo

- Archive id: doi:10.1056/nejmoa2212948
- Published: 2022-11-30
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2212948
- PMID: 36449413
- Citations: 5,673
- Source URL: https://doi.org/10.1056/nejmoa2212948
- PDF: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2212948?articleTools=true
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

Cited in dossiers:
- [Alzheimer's, Parkinson's & Neurodegeneration: State of the Field (October 2026)](https://space-kitty.com/dossiers/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.